a complete buyout ....and why they are divesting....they were told to by.....ROCHE?
so average in on this downturn
turns positive....Ichan may still make a move
Abstral an exclusive with Caremark as of April 1 ( 32 million potential patients ). and Prime Therapeutics added Abstral to it's Medicare part D...1.2 million patients
$4 + would be good.....really not concerned with the number...more the pipeline
In good time
Machines will go away...Hiliarys next quest
but the democrats will at least turn off the machines
The science is intact,,,as the NIC gives GALE a vote of Confidence
and nice pipeline is very encouraging,,,,make sure ur sell price is 7 or above for shorts to cover
Very Positive Data and standard of care potential...with new indications
trials and NCI partner,,,,,,,,I don't see anything wrong thiis
in high risk patients,,,,which I suspect is the next big thing,,,, ?
Term GALE looks great